DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Bumetanide (Bumetanide) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (5)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Bumetanide life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Bumetanide side effects in 71 year old male

Reported by a consumer/non-health professional from United States on 2012-05-29

Patient: 71 year old male, weighing 89.8 kg (197.6 pounds)

Reactions: Skin Discolouration, Oedema Peripheral, Skin Haemorrhage, Gait Disturbance, DRY Skin

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Bumetanide

Other drugs received by patient: Glimepiride; Lisinopril; Warfarin Sodium; Metoprolol Tartrate



Possible Bumetanide side effects in 75 year old male

Reported by a pharmacist from United Kingdom on 2012-05-21

Patient: 75 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Dyspnoea, Malaise, Diarrhoea, Wrong Drug Administered, Bradycardia, Drug Dispensing Error, Lethargy

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Bisoprolol Fumarate
    Dosage: 5 mg, five times a day
    Administration route: Oral
    Start date: 2012-02-29

Bumetanide
    Dosage: unk

Other drugs received by patient: Allopurinol; Amiodarone HCL



Possible Bumetanide side effects in 75 year old male

Reported by a physician from Norway on 2012-02-07

Patient: 75 year old male

Reactions: Confusional State, Peripheral Coldness, Ventricular Hypokinesia, Hyperkalaemia, Electrocardiogram T Wave Abnormal, Hypovolaemia, Metabolic Acidosis, Hypotension, Heart Valve Incompetence, General Physical Health Deterioration, Electrocardiogram QRS Complex Abnormal, Cardiogenic Shock, Cardiac Output Decreased, Renal Failure, Heart Rate Decreased, Ejection Fraction Decreased, Oliguria, Bradycardia, Altered State of Consciousness, Electrocardiogram P Wave Abnormal

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Metoprolol
    Dosage: 100 mg, qam
    Indication: Cardiac Failure

Digoxin
    Dosage: 50 mcg, qam
    Indication: Cardiac Failure

Bumetanide
    Dosage: 1.5 mg, qam
    Indication: Cardiac Failure

Ramipril
    Dosage: 10 mg, qam

Spironolactone
    Dosage: 25 mg, qam



Possible Bumetanide side effects in 75 year old male

Reported by a physician from Norway on 2012-01-25

Patient: 75 year old male

Reactions: Confusional State, Peripheral Coldness, Ventricular Hypokinesia, Hyperkalaemia, Electrocardiogram T Wave Abnormal, Hypovolaemia, Metabolic Acidosis, Heart Valve Incompetence, Hypotension, General Physical Health Deterioration, Electrocardiogram QRS Complex Abnormal, Cardiogenic Shock, Cardiac Output Decreased, Renal Failure, Heart Rate Decreased, Ejection Fraction Decreased, Oliguria, Bradycardia, Altered State of Consciousness, Electrocardiogram P Wave Abnormal

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Metoprolol
    Dosage: 100 mg, qam
    Indication: Cardiac Failure

Digoxin
    Dosage: 50 mcg, qam
    Indication: Cardiac Failure

Bumetanide
    Dosage: 1.5 mg, qam
    Indication: Cardiac Failure

Spironolactone
    Dosage: 25 mg, qam

Ramipril
    Dosage: 10 mg, qam



Possible Bumetanide side effects in male

Reported by a physician from United Kingdom on 2011-11-29

Patient: male, weighing 99.0 kg (217.8 pounds)

Reactions: Renal Impairment, Cardiac Arrest, Lower Respiratory Tract Infection, Disease Progression

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Bumetanide
    Dosage: 2 mg, qd
    Indication: Cardiac Failure
    Start date: 2009-04-09
    End date: 2011-04-13

Blinded Aliskiren
    Dosage: no treatment
    Indication: Cardiac Failure

Enalapril Maleate
    Dosage: no treatment
    Indication: Cardiac Failure

Enalapril Maleate
    Dosage: 20 mg, bid
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2011-04-01
    End date: 2011-04-14

Eplerenone
    Dosage: 50 mg, qd
    Indication: Cardiac Failure
    Start date: 2010-10-13
    End date: 2011-04-14

Blinded NO Treatment Received
    Dosage: no treatment
    Indication: Cardiac Failure

Other drugs received by patient: Warfarin Sodium; Amitriptyline HCL; Nebivolol HCL; Amiodarone HCL

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017